# How Not To Run an A/B Test
By Evan Miller; April 18, 2010; Translations: Russian Uzbek

> If you run A/B tests on your website and regularly check ongoing experiments***(å®éªŒ)*** for significant***(æ˜¾è‘—)*** results, you might be falling prey to***(å—â€¦â€¦å½±å“)***  what statisticians call repeated significance testing errors***(é‡å¤çš„æ˜¾è‘—æ£€éªŒè¯¯å·®)*** . As a result, even though your dashboard says a result is statistically significant, thereâ€™s a good chance***(å¾ˆæœ‰å¯èƒ½æ˜¯)*** that itâ€™s actually insignificant. This note explains why.

## Background

When an A/B testing dashboard says there is a â€œ95% chance of beating original***(æ‹’ç»åŸå‡è®¾ï¼Ÿ)***â€ or â€œ90% probability of statistical significance,â€ itâ€™s asking the following question: Assuming***(å‡è®¾)*** there is no underlying***(æ ¹æœ¬çš„)*** difference between A and B, how often will we see a difference like we do in the data just by chance***(å¶å°”)***? The answer to that question is called the significance level***(æ˜¾è‘—æ°´å¹³)***, and â€œstatistically significant resultsâ€ mean that the significance level is low, e.g. ***(ä¾‹å¦‚(æºè‡ªæ‹‰ä¸æ–‡exempli gratia))***5% or 1%. Dashboards usually take the complement***(è¡¥å……)*** of this (e.g. 95% or 99%) and report it as a â€œchance of beating the originalâ€ or something like that.

However, the significance calculation makes a critical ***(æŒ‘å‰”çš„ã€ä¸¥è°¨çš„)*** assumption that you have probably violated without even realizing it: that the sample size was fixed in advance. If instead of deciding ahead of time, â€œthis experiment will collect exactly 1,000 observations,â€ you say, â€œweâ€™ll run it until we see a significant difference,â€ all the reported significance levels become meaningless. This result is completely counterintuitive and all the A/B testing packages out there ignore it, but Iâ€™ll try to explain the source of the problem with a simple example.

## Example
Suppose you analyze an experiment after 200 and 500 observations. There are four things that could happen:

| |Scenario 1|Scenario 2|Scenario 3|Scenario 4|
|:----|:----|:----|:----|:----|
|After 200 observations | Insignificant | Insignificant | Significant! | Significant! |
|After 500 observations | Insignificant | Significant! | Insignificant | Significant! |
|End of experiment       | Insignificant | Significant! | Insignificant | Significant! |


Assuming treatments A and B are the same and the significance level is 5%, then at the end of the experiment, weâ€™ll have a significant result 5% of the time.

But suppose we stop the experiment as soon as there is a significant result. Now look at the four things that could happen:

| |Scenario 1|Scenario 2|Scenario 3|Scenario 4|
|:----|:----|:----|:----|:----|
|After 200 observations | Insignificant | Insignificant | Significant! | Significant! |
|After 500 observations | Insignificant | Significant! | trial stopped | trial stopped |
|End of experiment       | Insignificant | Significant! | Significant! | Significant! |


The first row is the same as before, and the reported significance levels after 200 observations are perfectly fine. But now look at the third row. At the end of the experiment, assuming A and B are actually the same, weâ€™ve increased the ratio of significant relative to insignificant results. Therefore, the reported significance level â€“ the â€œpercent of the time the observed difference is due to chanceâ€ â€“ will be wrong.

## How big of a problem is this?
Suppose your conversion rate is 50% and you want to test to see if a new logo gives you a conversion rate of more than 50% (or less). You stop the experiment as soon as there is 5% significance, or you call off the experiment after 150 observations. Now suppose your new logo actually does nothing. What percent of the time will your experiment wrongly find a significant result? No more than five percent, right? Maybe six percent, in light of the preceding analysis?

Try 26.1% â€“ more than five times what you probably thought the significance level was. This is sort of a worst- case scenario, since weâ€™re running a significance test after every observation, but itâ€™s not unheard-of. At least one A/B testing framework out there actually provides code for automatically stopping experiments after there is a significant result. That sounds like a neat trick until you realize itâ€™s a statistical abomination.
    
 Repeated significance testing always increases the rate of false positives, that is, youâ€™ll think many insignificant results are significant (but not the other way around). The problem will be present if you ever find yourself â€œpeekingâ€ at the data and stopping an experiment that seems to be giving a significant result. The more you peek, the more your significance levels will be off. For example, if you peek at an ongoing experiment ten times, then what you think is 1% significance is actually just 5% significance. Here are other reported significance values you need to see just to get an actual significance of 5%:

|You peeked... | To get 5% actual significance you need |
|:----|:----|
|1 time |2.9% reported significance|
|2 times |2.2% reported significance|
|3 times |1.8% reported significance|
|5 times |1.4% reported significance|
|10 times |1.0% reported significance|


Decide for yourself how big a problem you have, but if you run your business by constantly checking the results of ongoing A/B tests and making quick decisions, then this table should give you goosebumps.

## What can be done?
If you run experiments: the best way to avoid repeated significance testing errors is to not test significance repeatedly. Decide on a sample size in advance and wait until the experiment is over before you start believing the â€œchance of beating originalâ€ figures that the A/B testing software gives you. â€œPeekingâ€ at the data is OK as long as you can restrain yourself from stopping an experiment before it has run its course. I know this goes against something in human nature, so perhaps the best advice is: no peeking!

Since you are going to fix the sample size in advance, what sample size should you use? This formula is a good rule of thumb:

$$ n = 16\dfrac{\sigma^2}{\delta^2} $$

Where $$\delta $$ is the minimum effect you wish to detect and $$\sigma^2$$ is the sample variance you expect. Of course you might not know the variance, but if itâ€™s just a binomial proportion youâ€™re calculating (e.g. a percent conversion rate) the variance is given by:

$$\sigma^2 = p(1-p)$$

Committing to a sample size completely mitigates the problem described here.

**UPDATE, May 2013:** You can see this formula in action with my new interactive [Sample Size Calculator](https://www.evanmiller.org/ab-testing/sample-size.html). Enter the effect size you wish to detect, set the power and significance levels, and you'll get an easy-to-read number telling you the sample size you need. **END OF UPDATE**

If you write A/B testing software: Donâ€™t report significance levels until an experiment is over, and stop using significance levels to decide whether an experiment should stop or continue. Instead of reporting significance of ongoing experiments, report how large of an effect can be detected given the current sample size. That can be calculated with:

$$\delta = (t_{\alpha/2}+t_\beta)\sigma\sqrt{2/n} $$

Where the two ğ‘¡â€™s are the t-statistics for a given significance level $$ğ›¼/2$$ and power $$(1-\beta)$$.

Painful as it sounds, you may even consider excluding the â€œcurrent estimateâ€ of the treatment effect until the experiment is over. If that information is used to stop experiments, then your reported significance levels are garbage.

If you really want to do this stuff right: Fixing a sample size in advance can be frustrating. What if your change is a runaway hit, shouldnâ€™t you deploy it immediately? This problem has haunted the medical world for a long time, since medical researchers often want to stop clinical trials as soon as a new treatment looks effective, but they also need to make valid statistical inferences on their data. Here are a couple of approaches used in medical experiment design that someone really ought to adapt to the web:

- **Sequential experiment design:** Sequential experiment design lets you set up checkpoints in advance where you will decide whether or not to continue the experiment, and it gives you the correct significance levels.

	Learn more: â€œ[Simple Sequential A/B Testing](https://www.evanmiller.org/sequential-ab-testing.html)â€

- **Bayesian experiment design:** With Bayesian experiment design you can stop your experiment at any time and make perfectly valid inferences. Given the real-time nature of web experiments, Bayesian design seems like the way forward.

	Learn more: â€œ[Bayesian A/B Testing](https://www.evanmiller.org/bayesian-ab-testing.html)â€ 

## Conclusion
	
Although they seem powerful and convenient, dashboard views of ongoing A/B experiments invite misuse. Any time they are used in conjunction with a manual or automatic â€œstopping rule,â€ the resulting significance tests are simply invalid. Until sequential or Bayesian experiment designs are implemented in software, anyone running web experiments should only run experiments where the sample size has been fixed in advance, and stick to that sample size with near- religious discipline.

------

## Further reading

### Repeated Significance Tests
P. Armitage, C. K. McPherson, and B. C. Rowe. â€œSignificance Tests on Accumulating Data,â€ Journal of the Royal Statistical Society. Series A (General), Vol. 132, No. 2 (1969), pp. 235-244

### Optimal Sample Sizes
John A. List, Sally Sadoff, and Mathis Wagner. â€œSo you want to run an experiment, now what? Some Simple Rules of Thumb for Optimal Experimental Design.â€ NBER Working Paper No. 15701

Wheeler, Robert E. â€œPortable Power,â€ Technometrics, Vol. 16, No. 2 (May, 1974), pp. 193-201

### Sequential Experiment Design
Pocock, Stuart J. â€œGroup Sequential Methods in the Design and Analysis of Clinical Trials,â€ Biometrika, Vol. 64, No. 2 (Aug., 1977), pp. 191-199

Pocock, Stuart J. â€œInterim Analyses for Randomized Clinical Trials: The Group Sequential Approach,â€ Biometrics, Vol. 38, No. 1 (Mar., 1982), pp. 153-162

### Bayesian Experiment Design
Berry, Donald A. â€œBayesian Statistics and the Efficiency and Ethics of Clinical Trials,â€ Statistical Science, Vol. 19, No. 1 (Feb., 2004), pp. 175-187

----

Youâ€™re reading [evanmiller.org](https://www.evanmiller.org), a random collection of math, tech, and musings. If you liked this you might also enjoy:

- [The Low Base Rate Problem](https://www.evanmiller.org/the-low-base-rate-problem.html) 
- [Simple Sequential A/B Testing](https://www.evanmiller.org/sequential-ab-testing.html) 
- [Formulas for Bayesian A/B Testing](https://www.evanmiller.org/bayesian-ab-testing.html)

----

Get new articles as theyâ€™re published, via Twitter or RSS.

----
            